Promising new antibiotic is one of first viable gonorrhea drug candidates since 1990s

Gonorrhea is on the verge of incurability, with just one antibiotic that still reliably works against the sexually transmitted infection. But on Monday, The Lancet medical journal reported successful trial results for a promising new antibiotic, making it one of the first viable gonorrhea drug candidates to come along since the 1990s.“This is very, very exciting. I didn’t think I would see it,” says Vanessa Allen, a medical microbiologist and infectious disease physician with Sinai Health who was not involved with the study but has extensively studied drug-resistant gonorrhea.